Company intelligence / Profile preview

IVAX

Miami, Florida, United Statesivax.com ↗
Ownership
Private
Development stage
Other
01

Overview

IVAX was a major generic and branded pharmaceutical company that operated commercially with products across multiple therapeutic areas before being acquired by Teva in 2006

Therapeutic areas
OncologyPulmonologyNeurology
Modalities
Small molecule
Industry
Biotech
02

Partnerships

Hafslund Nycomed

Beyond the preview

Go deeper on IVAX.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on IVAX.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call